Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Aster DM Quality Care's Equity-to-Asset or its related term are showing as below:
NSE:ASTERDM'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25 Med: 0.3 Max: 0.58
Current: 0.56
During the past 12 years, the highest Equity to Asset Ratio of Aster DM Quality Care was 0.58. The lowest was 0.25. And the median was 0.30.
NSE:ASTERDM's Equity-to-Asset is ranked better than 58.13% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs NSE:ASTERDM: 0.56
Aster DM Quality Care (NSE:ASTERDM) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Aster DM Quality Care Equity-to-Asset Related Terms
Aster DM Quality Care Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Aster DM Quality Care's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTERDM vs HCA, THC, DVA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Aster DM Quality Care's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aster DM Quality Care (NSE:ASTERDM) has a Equity-to-Asset of 0.00 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aster DM Quality Care and its competitors. Over the past decade, Aster DM Quality Care's Equity-to-Asset has ranged from 0.25 to 0.58. According to the industry distribution chart, Aster DM Quality Care ranks #286 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 41.9%.
Is Aster DM Quality Care's Equity-to-Asset too high?
Aster DM Quality Care's current Equity-to-Asset is 0.00. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.58. Based on the distribution chart, Aster DM Quality Care ranks #286 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Aster DM Quality Care has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #286 out of 683 companies for Equity-to-Asset. This puts Aster DM Quality Care in the upper half of its industry. The industry median Equity-to-Asset is 0.48. Historically, Aster DM Quality Care's own Equity-to-Asset has ranged from 0.25 to 0.58 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aster DM Quality Care and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current Equity-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹601.15, compared to a current price of ₹869.70 — trading 44.7% above its estimated fair value. The current Equity-to-Asset is 0.00. Aster DM Quality Care's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current Equity-to-Asset is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹869.70 is trading 44.7% above its estimated GF Value™ of ₹601.15.
GuruFocus considers Aster DM Quality Care to be Significantly Overvalued.
Key valuation signals for NSE:ASTERDM:
Equity-to-Asset: 0.00
GF Value™: ₹601.15 vs. price of ₹869.70 (44.7% above fair value)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
67GF Score
Get the complete analysis for NSE:ASTERDM
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 
